The Evolving Role of Whole Breast Hypofractionation in Older Patients With Early Breast Cancer

被引:2
作者
Kunkler, Ian [1 ]
机构
[1] Univ Edinburgh, Inst Genet & Canc, Edinburgh, Scotland
关键词
RADIOTHERAPY HYPOFRACTIONATION; RADIATION-THERAPY; SCHEDULES;
D O I
10.1016/j.semradonc.2021.11.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer in older patients presents an increasing health care challenge. Hypofractionated dose schedules of 15/16 daily fractions of postoperative radiotherapy over 3/3.5 weeks have been established in clinical trials with long term follow up as safe and effective and become the standard of care after breast conserving therapy for most older patients. Emerging clinical trial data are pushing the limits of hypofractionation to even shorter schedules over a week. In this mini-review the applicability of this new data to older patients is discussed and the development of guidelines for hypofractionated dose fractionation schedules adapted to the COVID19 pandemic for this age group. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:155 / 158
页数:4
相关论文
共 15 条
  • [1] Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the International Society of Geriatric Oncology (SIOG)
    Biganzoli, Laura
    Battisti, Nicole Matteo Luca
    Wildiers, Hans
    McCartney, Amelia
    Colloca, Giuseppe
    Kunkler, Ian H.
    Cardoso, Maria-Joao
    Cheung, Kwok-Leung
    de Glas, Nienke Aafke
    Trimboli, Rubina M.
    Korc-Grodzicki, Beatriz
    Soto-Perez-de-Celis, Enrique
    Ponti, Antonio
    Tsang, Janice
    Marotti, Lorenza
    Benn, Karen
    Aapro, Matti S.
    Brain, Etienne G. C.
    [J]. LANCET ONCOLOGY, 2021, 22 (07) : E327 - E340
  • [2] FAST Phase III RCT of Radiotherapy Hypofractionation for Treatment of Early Breast Cancer: 10-Year Results (CRUKE/04/015)
    Brunt, A. M.
    Haviland, J.
    Sydenham, M.
    Algurafi, H.
    Alhasso, A.
    Bliss, P.
    Bloomfield, D.
    Emson, M.
    Goodman, A.
    Harnett, A.
    Passant, H.
    Tsang, Y. M.
    Wheatley, D.
    Bliss, J.
    Yarnold, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (05): : 1603 - 1604
  • [3] Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer
    Brunt, Adrian Murray
    Haviland, Joanne S.
    Sydenham, Mark
    Agrawal, Rajiv K.
    Algurafi, Hafiz
    Alhasso, Abdulla
    Barrett-Lee, Peter
    Bliss, Peter
    Bloomfield, David
    Bowen, Joanna
    Donovan, Ellen
    Goodman, Andy
    Harnett, Adrian
    Hogg, Martin
    Kumar, Sri
    Passant, Helen
    Quigley, Mary
    Sherwin, Liz
    Stewart, Alan
    Syndikus, Isabel
    Tremlett, Jean
    Tsang, Yat
    Venables, Karen
    Wheatley, Duncan
    Bliss, Judith M.
    Yarnold, John R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (28) : 3261 - 3272
  • [4] Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
    Brunt, Adrian Murray
    Haviland, Joanne S.
    Wheatley, Duncan A.
    Sydenham, Mark A.
    Alhasso, Abdulla
    Bloomfield, David J.
    Chan, Charlie
    Churn, Mark
    Cleator, Susan
    Coles, Charlotte E.
    Goodman, Andrew
    Harnett, Adrian
    Hopwood, Penelope
    Kirby, Anna M.
    Kirwan, Cliona C.
    Morris, Carolyn
    Nabi, Zohal
    Sawyer, Elinor
    Somaiah, Navita
    Stones, Liba
    Syndikus, Isabel
    Bliss, Judith M.
    Yarnold, John R.
    [J]. LANCET, 2020, 395 (10237) : 1613 - 1626
  • [5] International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic
    Coles, C. E.
    Aristei, C.
    Bliss, J.
    Boersma, L.
    Brunt, A. M.
    Chatterjee, S.
    Hanna, G.
    Jagsi, R.
    Person, O. Kaidar
    Kirby, A.
    Mjaaland, I.
    Meattini, I.
    Luis, A. M.
    Marta, G. N.
    Offersen, B.
    Poortmans, P.
    Rivera, S.
    [J]. CLINICAL ONCOLOGY, 2020, 32 (05) : 279 - 281
  • [6] The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials
    Haviland, Joanne S.
    Owen, J. Roger
    Dewar, John A.
    Agrawal, Rajiv K.
    Barrett, Jane
    Barrett-Lee, Peter J.
    Dobbs, H. Jane
    Hopwood, Penelope
    Lawton, Pat A.
    Magee, Brian J.
    Mills, Judith
    Simmons, Sandra
    Sydenham, Mark A.
    Venables, Karen
    Bliss, Judith M.
    Yarnold, John R.
    [J]. LANCET ONCOLOGY, 2013, 14 (11) : 1086 - 1094
  • [7] Moderate hypofractionation remains the standard of care for whole-breast radiotherapy in breast cancer: Considerations regarding FAST and FAST-Forward
    Krug, David
    Baumann, Rene
    Combs, Stephanie E.
    Duma, Marciana Nona
    Dunst, Juergen
    Feyer, Petra
    Fietkau, Rainer
    Haase, Wulf
    Harms, Wolfgang
    Hehr, Thomas
    Piroth, Marc D.
    Sedlmayer, Felix
    Souchon, Rainer
    Strnad, Vratislav
    Budach, Wilfried
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (04) : 269 - 280
  • [8] 1-week hypofractionated adjuvant whole-breast radiotherapy: towards a new standard? Comment
    Levy, Antonin
    Rivera, Sofia
    [J]. LANCET, 2020, 395 (10237) : 1588 - 1589
  • [9] Hypofractionated Versus Standard Fractionated Radiotherapy in Patients With Early Breast Cancer or Ductal Carcinoma In Situ in a Randomized Phase III Trial: The DBCG HYPO Trial
    Offersen, Birgitte V.
    Alsner, Jan
    Nielsen, Hanne M.
    Jakobsen, Erik H.
    Nielsen, Mette H.
    Krause, Mechthild
    Stenbygaard, Lars
    Mjaaland, Ingvil
    Schreiber, Andreas
    Kasti, Unn-Miriam
    Overgaard, Jens
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (31) : 3615 - +
  • [10] Hypofractionated Whole-Breast Irradiation: Case Closed?
    Recht, Abram
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (31) : 3584 - +